About the Company

[Summary] 多能干细胞药物的高新技术企业

意胜生物(EssentiaBioSciences)成立于2021年底,是一家专注于利用多能干细胞诱导分化胰岛组织的创新型细胞药研发公司。目标是通过多能干细胞在体外分化再生健康的胰岛组织,从源头治愈胰岛素依赖型糖尿病。该公司已经开发多条胰岛药物相关管线,其中进展*快的项目是多能干细胞分化胰岛细胞药物(ESN5800),已经完成了研发和生产的技术路线验证,正式进入产业化阶段。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

意胜生物 Financing History (7 rounds)

Manage
Pre-A轮
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Amount: 近亿人民币
  • Investor: 海尔,元生创投,清科创投,...

意胜生物 honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

意胜生物 Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 714.2083万(元)
Legal Representative: 刘彤日
Date Established:
Credit Code: 91110102MA04DNLD4W
Registered Address: 北京市大兴区礼贤镇集运街2号院自贸试验区大兴机场片区综合保税区8号楼301号

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates